Table 3.
Range of immunohistochemistry (IHC) scores for single antibodies
IHC score | |||||
---|---|---|---|---|---|
AP2beta | 0 | 1 + | 2+ | 3+ | 4+ |
ERMS/ARMS TMA | |||||
Translocation negative (N=33) | 85% | 6% | 3% | 0% | 6% |
Translocation positive (N=28) | 0% | 4% | 4% | 11% | 82% |
Lookback TMA | |||||
Translocation negative (N=26) | 77% | 4% | 12% | 8% | 0% |
Translocation positive (N=24) | 0% | 8% | 0% | 8% | 83% |
NOS-1 | |||||
ERMS/ARMS TMA | |||||
Translocation negative (N=33) | 27% | 48% | 18% | 3% | 3% |
Translocation positive (N=28) | 7% | 3% | 7% | 29% | 54% |
Lookback TMA | |||||
Translocation negative (N=26) | 77% | 19% | 0% | 0% | 4% |
Translocation positive (N=24) | 17% | 8% | 4% | 29% | 42% |
Myogenin | |||||
ERMS/ARMS TMA | |||||
Translocation negative (N=33) | 0% | 21% | 30% | 39% | 9% |
Translocation positive (N=28) | 0% | 0% | 0% | 21% | 79% |
Lookback TMA | |||||
Translocation negative (N=26) | 0% | 27% | 38% | 23% | 12% |
Translocation positive (N=24) | 0% | 4% | 0% | 13% | 83% |
HMGA2 | |||||
ERMS/ARMS TMA | |||||
Translocation negative (N=33) | 9% | 18% | 0% | 21% | 52% |
Translocation positive (N=28) | 61% | 21% | 7% | 7% | 4% |
Lookback TMA | |||||
Translocation negative (N=26) | 8% | 12% | 0% | 15% | 65% |
Translocation positive (N=24) | 37% | 42% | 4% | 13% | 4% |